Apimeds Pharmaceuticals US, Inc.
APUSApimeds Pharmaceuticals US, Inc. (APUS) is a pharmaceutical company focused on the development, manufacturing, and distribution of medical and health-related products. The company aims to provide innovative solutions in healthcare through its portfolio of specialized medicines and treatments.
$0.66 +0.01 (0.76%)
Company News
APUS Investors Have Opportunity to Join Apimeds Pharmaceuticals US, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm is investigating Apimeds Pharmaceuticals US, Inc. (APUS), Elite Express Holding Inc. (ETS), and Decent Holding Inc. (DXST) for potential securities law violations, including allegations of false statements and failure to disclose material information to investors. Affected shareholders are encouraged to participate in the inve...
